ReviewBMJ (Clinical research ed.)2012
Second generation endometrial ablation techniques for heavy menstrual bleeding: network meta-analysis.
Review in BMJ (Clinical research ed.), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 5 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 5 syntheses or guidelines pooled it.
- Pooled it
- Interventions for heavy menstrual bleeding; overview of Cochrane reviews and network meta-analysis.The Cochrane database of systematic reviews · 2022Pooled it
- Endometrial resection and ablation techniques for heavy menstrual bleeding.The Cochrane database of systematic reviews · 2019Pooled it
- Pre-operative endometrial thinning agents before endometrial destruction for heavy menstrual bleeding.The Cochrane database of systematic reviews · 2013Pooled it
- Use of mixed-treatment-comparison methods in estimating efficacy of treatments for heavy menstrual bleeding.European journal of medical research · 2013Pooled it
- Contacting authors to retrieve individual patient data: study protocol for a randomized controlled trial.Trials · 2016Trial
- Trial
- Anticoagulant therapy for women: implications for menstruation, pregnancy, and lactation.Hematology. American Society of Hematology. Education Program · 2022Article
- CavatermCaspian journal of internal medicine · 2021Article
- Predictors of a Successful Bipolar Radiofrequency Endometrial Ablation.Geburtshilfe und Frauenheilkunde · 2019Article
- Efficacy and patient satisfaction after NovaSure and Minerva endometrial ablation for treating abnormal uterine bleeding: a retrospective comparative study.International journal of women's health · 2018Article
- A scoping review of indirect comparison methods and applications using individual patient data.BMC medical research methodology · 2016Article
- Design and fabrication of a miniature objective consisting of high refractive index zinc sulfide lenses for laser surgery.Optical engineering (Redondo Beach, Calif.) · 2016Article
- Economic and clinical benefits of endometrial radiofrequency ablation compared with other ablation techniques in women with menorrhagia: a retrospective analysis with German health claims data.International journal of women's health · 2016Article
- Thermal balloon endometrial ablation in the treatment of heavy menstrual bleeding.Medical archives (Sarajevo, Bosnia and Herzegovina) · 2014Article
- Network meta-analysis of randomized clinical trials: reporting the proper summaries.Clinical trials (London, England) · 2014Article
- Ten-year literature review of global endometrial ablation with the NovaSure® device.International journal of women's health · 2014Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
objectiveTo determine the relative effectiveness of second generation ablation techniques in the treatment of heavy menstrual bleeding.
designNetwork meta-analysis on the primary outcome measures of amenorrhoea, heavy bleeding, and patients' dissatisfaction with treatment. DATA SOURCES: Nineteen randomised controlled trials (involving 3287 women) were identified through electronic searches of the Cochrane Library, Medline, Embase and PsycINFO databases from inception to April 2011. The reference lists of known relevant articles were searched for further articles. Two reviewers independently selected articles without language restrictions. ELIGIBILITY CRITERIA FOR SELECTING STUDIES: Randomised controlled trials involving second generation endometrial destruction techniques for women with heavy menstrual bleeding unresponsive to medical treatment.
resultsOf the three most commonly used techniques, network meta-analysis showed that bipolar radiofrequency and microwave ablation resulted in higher rates of amenorrhoea than thermal balloon ablation at around 12 months (odds ratio 2.51, 95% confidence interval 1.53 to 4.12, P<0.001; and 1.66, 1.01 to 2.71, P=0.05, respectively), but there was no evidence of a convincing difference between the three techniques in the number of women dissatisfied with treatment or still experiencing heavy bleeding. Compared with bipolar radio frequency and microwave devices, an increased number of women still experienced heavy bleeding after free fluid ablation (2.19, 1.07 to 4.50, P=0.03; and 2.91, 1.23 to 6.88, P=0.02, respectively). Compared with radio frequency ablation, free fluid ablation was associated with reduced rates of amenorrhoea (0.36, 0.19 to 0.67, P=0.004) and increased rates of dissatisfaction (4.79, 1.07 to 21.5, P=0.04). Of the less commonly used devices, endometrial laser intrauterine thermotherapy was associated with increased rates of amenorrhoea compared with all the other devices, while cryoablation led to a reduced rate compared with bipolar radio frequency and microwave.
conclusionsBipolar radio frequency and microwave ablative devices are more effective than thermal balloon and free fluid ablation in the treatment of heavy menstrual bleeding with second generation endometrial ablation devices.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.